Similar findings were reported for TLR4 signaling and paclitaxel chemoresistance in ovarian cancer [14] suggesting a putative role of TLR4 signaling in the development of chemoresistant cancer cells. This evidence concerns the gene TLR4 and ovarian carcinoma.